Publications

This document describes the processes to determine fees for applications to provide medicines subsidised by the Pharmaceutical Benefits Scheme. It also outlines the current and forecasted financial performance of the process.

Weekly report of year to date immunisation figures broken down by age groups and immunising provider types. Compares vaccination rates with the previous 3 years.

The AGPT program Performance and Outcomes Framework (the Framework) aims to improve the effectiveness, efficiency, transparency and accountability of the AGPT program by providing a structured approach to tracking, measuring and reporting on progress towards the program’s objectives and outcomes.

Quarterly Financial Reporting frequently asked questions for aged care providers to use as a guide when collating their financial information.

View the community kit for more information about MyMedicare eligibility, registration, and communication resources.

A guide to help providers identify opportunities to improve their Star Ratings.

This document guides aged care providers on how to provide Monthly Care Statements to their residents.

The draft departmental report summarises the review process and outcomes. Stakeholders can provide feedback on the proposed recommendations.

This is the Australian Governments response to the Joint Standing Committees recommendations on the National Disability Insurance Scheme Report.

Appliance Scheme product utilisation data quarterly report for January to March 2026.

The Hospital Casemix Protocol (HCP) data specification for General Treatment-Dental files for 2026–27 details the financial, clinical and demographic data that hospitals must provide private health insurers. Private health insurers must then provide this data to us. Effective from 1 July 2026.

The Hospital Casemix Protocol (HCP) data specification for HCP1 files for 2026–27 details the financial, clinical and demographic data that hospitals must provide private health insurers. Private health insurers must then provide this data to us. Effective from 1 July 2026.

The Hospital Casemix Protocol (HCP) data specification for HCP2 files for 2026–27 details the financial, clinical and demographic data that hospitals must provide private health insurers. Private health insurers must then provide this data to us. Effective from 1 July 2026.

The Hospital Casemix Protocol (HCP) data specifications for HCP files details the financial, clinical and demographic data that hospitals must provide to private health insurers. Private health insurers must then provide this data to us. Effective from 1 July 2026.

The Private Health Data Bureau (PHDB) data specifications for 2024–25 details the financial, clinical and demographic data that hospitals must provide to us. Effective from 1 July 2026.

Information about premature, early and medically induced menopause.

his public interest certificate (PIC) relates to the following tender: Procurement of National Blood Stem Cell Donation Services.

This dashboard provides a snapshot of bulk billing for GP non referred attendances (GP NRA) and Medicare Bulk Billing Practices (those registered for the Bulk Billing Practice Incentive Program) for the January to March 2026 reporting quarter.

This information card gives guidance on what you should do if you have recently travelled to a region that is affected by MERS and develop symptoms of this disease.

This document contains statistics about the use of the Dental Benefits Schedule in each state and territory, from March quarter 2008–09 to March quarter 2025–26.

This user guide for hospitals and private health insurers explains how to submit Hospital Casemix Protocol (HCP) and Private Hospital Data Bureau (PHDB) data.

This document contains information about the calculation and interpretation of Medicare Statistics

The Commonwealth, state and territory Disability Ministers met on 22 May 2026. This document provides a record of the meeting.

The ‘menopause transition’ includes perimenopause and menopause.  During the menopause transition the levels of oestrogen and progesterone, hormones produced by the ovaries, change. This causes menopause-related symptoms.   People might also describe these symptoms as ‘perimenopause symptoms’.

Partners, family and friends play an important role in supporting their loved one through the menopause transition.